Clinical Trial Update: A Study of GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting completion of a study evaluating GRN163L in combination with paclitaxel and bevacizumab for locally recurrent or metastatic breas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• GRN163L (imetelstat)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Geron Corporation | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED